Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Feb 9, 2020
Date Accepted: Dec 15, 2020

The final, peer-reviewed published version of this preprint can be found here:

He Korowai Manaaki (Pregnancy Wraparound Care): Protocol for a Cluster Randomized Clinical Trial

Lawton B, Storey F, Sibanda N, Bennett M, Lambert C, Geller S, Edmonds L, Cram F

He Korowai Manaaki (Pregnancy Wraparound Care): Protocol for a Cluster Randomized Clinical Trial

JMIR Res Protoc 2021;10(1):e18154

DOI: 10.2196/18154

PMID: 33512321

PMCID: 7880808

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

He Korowai Manaaki (Pregnancy Wraparound Care): Study Protocol for a Cluster Randomised Clinical Trial

  • Bev Lawton; 
  • Francesca Storey; 
  • Nokuthaba Sibanda; 
  • Matthew Bennett; 
  • Charles Lambert; 
  • Stacie Geller; 
  • Liza Edmonds; 
  • Fiona Cram

ABSTRACT

Background:

Maternal and infant health inequities between Māori (the Indigenous peoples of Aotearoa New Zealand) and New Zealand European (NZE) women are well documented and cannot be explained solely by socioeconomic status. This research centre-iwi (tribal) partnership aims to address these disparities and improve maternal and infant health outcomes by implementing an augmented maternity care pathway (He Korowai Manaaki) to improve access to services and evidence based care.

Objective:

The objective of this study is to test whether an augmented maternity care pathway improves Māori infant health outcomes.

Methods:

This is a Kaupapa Māori study with a cluster randomised clinical trial involving eight primary care practices allocated to the intervention or control arm. The intervention arm comprises an augmented maternity care pathway (He Korowai Manaaki) addressing both clinical and structural determinants of health (e.g. housing, transport etc.). It includes additional paid health care appointments, wraparound support and connections to allied services as appropriate. The control arm is usual care. Primary outcomes are reduction in hospitalisations and length of hospital stay and increase timely vaccinations for Māori infants in their first year of life.

Results:

Recruitment commenced in November 2018 and will be completed June 2020 to obtain the required sample size of 500 pregnancies (250 control, 250 intervention). Publication of results is anticipated late 2023.

Conclusions:

The results will inform primary health care policy as well as clinical pathways, including augmented pathways, and address structural determinants of health to strengthen the health and wellbeing of pregnant Māori women and their babies and improve the health outcomes for lifelong health and wellbeing. Clinical Trial: ACTRN12619001155189 Australian New Zealand Clinical Trials Registry http://www.ANZCTR.org.au/ACTRN12619001155189.aspx


 Citation

Please cite as:

Lawton B, Storey F, Sibanda N, Bennett M, Lambert C, Geller S, Edmonds L, Cram F

He Korowai Manaaki (Pregnancy Wraparound Care): Protocol for a Cluster Randomized Clinical Trial

JMIR Res Protoc 2021;10(1):e18154

DOI: 10.2196/18154

PMID: 33512321

PMCID: 7880808

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.